BROADWOOD CAPITAL INC
CIK 1278387 · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$839.84M
Companies
9
Total Filings
74
Lifetime Open-Market Net
$101.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 12,685,041 | $3.20 | $40.59M | $75.10M | 7 | 2026-04-27 |
| STAA | 10%+ Owner | 26,526,474 | $28.37 | $752.56M | $62.94M | 37 | 2025-04-07 |
| LCTX | 10%+ Owner | 68,730,970 | $1.27 | $87.29M | $4.03M | 2 | 2022-03-25 |
| BTX | 10%+ Owner | — | $9.03 | — | $0 | 2 | 2017-09-13 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | 10%+ Owner | 27,182,162 | — | — | $46.04M | 10 | 2017-02-17 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 1,282,050 | — | — | $0 | 1 | 2015-02-11 | |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 3,636,496 | — | — | -$92.74M | 4 | 2014-08-06 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,617,246 | — | — | $3.75M | 3 | 2012-06-28 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 3,051,668 | — | — | $2.35M | 7 | 2008-04-29 |
Recent Filings · Page 4 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-21 | STAA | Buy (P) | +218,574 | $1.47M | EDGAR |
| 2016-01-12 | STAA | Buy (P) | +259,758 | $1.77M | EDGAR |
| 2016-01-07 | STAA | Buy (P) | +801,141 | $5.57M | EDGAR |
| 2015-10-06 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | +4,800,000 | $15.31M | EDGAR |
| 2015-08-25 | STAA | Buy (P) | +566,643 | $4.06M | EDGAR |
| 2015-02-11 | Asterias Biotherapeutics, Inc. (AST) Delisted | Other (J) | +1,923,075 | $7.50M | EDGAR |
| 2014-11-07 | STAA | Buy (P) | +240,000 | $2.14M | EDGAR |
| 2014-11-04 | STAA | Buy (P) | +781,023 | $7.18M | EDGAR |
| 2014-10-08 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | +12,121,569 | $37.82M | EDGAR |
| 2014-08-18 | — | Mixed | −5,489,793 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.